Here is a detailed write-up on NACO:
National AIDS Control Organisation (NACO)
What is NACO?
The National AIDS Control Organisation (NACO) is a division of the Ministry of Health and Family Welfare (MoHFW), Government of India. It provides leadership, policy direction, and programmatic oversight for India's national HIV/AIDS and STI (Sexually Transmitted Infections) control response through 35 State AIDS Prevention and Control Societies (SACS).
NACO's vision is an India where every person living with HIV (PLHIV) receives quality care, free from stigma and discrimination. It focuses on awareness, prevention, early diagnosis, treatment access, and community empowerment.
Helpline: 1097 (Toll-Free, 24x7)
Historical Milestones
India's HIV response began the moment the first case was detected and has evolved steadily:
| Year | Milestone |
|---|
| 1986 | First case of HIV detected in India; AIDS Task Force set up by ICMR; National AIDS Committee established |
| 1987 | National AIDS Control Programme (NACP) launched |
| 1990 | Medium Term Plan launched for 4 states and 4 metro cities |
| 1992 | NACP Phase I launched; National AIDS Control Board constituted; NACO set up |
| 1999 | NACP Phase II begins - focus on behaviour change, decentralization, NGO involvement; State AIDS Control Societies (SACS) established |
| 2002 | National AIDS Control Policy adopted; National Blood Policy adopted |
| 2004 | Antiretroviral Treatment (ART) initiated under the national programme |
| 2006 | National Council on AIDS constituted under chairmanship of the Prime Minister; National Policy on Paediatric ART formulated |
| 2007 | NACP Phase III launched (2007-2012) |
| 2012 | NACP Phase IV launched (2012-2017) |
| 2017 | National Strategic Plan for HIV/AIDS and STIs (2017-2024) formulated |
| 2020 | Programme renamed to National AIDS and STD Control Programme |
| 2021 | NACP Phase V launched (2021-2026) |
(Source: Park's Textbook of Preventive and Social Medicine)
NACP Phases - Evolution of the Programme
NACP Phase I (1992-1999)
- Aimed at slowing down the spread of HIV infection
- Focused on surveillance, blood safety, and awareness generation
- Built foundational infrastructure: NACO, SACS, blood banks
NACP Phase II (1999-2006)
- Focus shifted to behaviour change communication (BCC)
- Increased decentralization of programme implementation
- Expanded NGO and civil society involvement
- Launched targeted interventions for high-risk groups (sex workers, MSM, IDUs)
NACP Phase III (2007-2012)
- Goal: Halt and reverse the HIV epidemic in India
- Scaled up targeted interventions, ART services, PPTCT
- Introduced Prevention of Parent to Child Transmission (PPTCT) as a major priority
- Expanded to all districts; classified districts into categories A, B, C, D based on epidemiological criteria
NACP Phase IV (2012-2017)
- Goal: Consolidate gains and accelerate reversal of the epidemic
- Targeted a 50% reduction in new infections from the 2007 baseline
- Provided comprehensive care and support to all PLHIV
- Introduced HIV-TB collaboration and provider-initiated testing
- Coverage of core high-risk groups (FSW, MSM, PWID) at 80%, 68%, 75% respectively by 2014-15
NACP Phase V (2021-2026)
NACP Phase V is a fully funded Central Scheme with a sanctioned budget of Rs. 15,471.94 crore. It integrates the UNAIDS Global AIDS Strategy (2021-2026) and WHO's Global Health Sector Strategies (2022-2030).
Five high-level goals of NACP Phase V:
- Reduce annual new HIV infections by 80% from the 2010 baseline by 2025-26
- Reduce AIDS-related mortalities by 80% from the 2010 baseline
- Eliminate vertical transmission (mother-to-child) of HIV and syphilis by 2025-26
- Achieve the 95-95-95 targets (see below)
- Eradicate HIV/AIDS-related stigma and discrimination
The 95-95-95 Targets
A central goal of NACP Phase V is achieving the UNAIDS 95-95-95 cascade:
| Target | Goal |
|---|
| 1st 95 | 95% of all PLHIV know their HIV status |
| 2nd 95 | 95% of those who know their status are on ART |
| 3rd 95 | 95% of those on ART have suppressed viral load |
India's progress (2020 data):
- 78% of PLHIV aware of their status
- 83% of diagnosed PLHIV on ART
- 85% of those on ART with viral suppression
Progress is significant but gaps remain, particularly in reaching the first 95.
Organisational Structure
NACO operates through a decentralized structure:
- National Level: NACO (Additional Secretary & Director General; Joint Secretary)
- Divisions: Targeted Intervention & LWS, Basic Services (ICTC, PPTCT, HIV-TB), STI/RTI Management, Blood Safety, Lab Services, Care/Support/Treatment, IEC, Strategic Information, Admin & Procurement, Finance
- State Level: 35 State AIDS Prevention and Control Societies (SACS)
- District Level: District AIDS Prevention and Control Units (DAPCUs)
- Facility Level: ART Centres, ICTCs, Link ART Centres, PPTCT facilities
Key Programme Components
1. Prevention - Targeted Interventions (TI)
Targeted interventions reach high-risk groups (HRGs) through outreach-based models, typically implemented by NGOs and community-based organisations:
- Female Sex Workers (FSWs)
- Men who have Sex with Men (MSM)
- People who Inject Drugs (PWID)
- Transgender persons
- Bridge populations: Long-distance truckers (LDT), single male migrants (SMM)
Services include condom promotion, STI treatment, behaviour change counselling, and linkage to HIV testing and treatment.
2. HIV Testing - Integrated Counselling and Testing Centres (ICTC)
ICTCs are the gateway to HIV diagnosis across India. They operate at:
- Fixed facility ICTCs - at hospitals and health facilities
- Mobile ICTCs - for outreach to remote/unreached populations
Testing can be client-initiated (voluntary) or provider-initiated (PITC). Functions include early detection, counselling on transmission and prevention, and linking PLHIV to care and treatment.
3. Prevention of Parent-to-Child Transmission (PPTCT)
- All pregnant women are tested for HIV at antenatal care
- HIV-positive pregnant women are started on lifelong ART (Option B+)
- Goal of NACP V: Eliminate vertical transmission (rate under 5%) by 2025-26
- As of 2023-24, states like Maharashtra, Delhi, and Andhra Pradesh have achieved ARV coverage of 90-95%+ among HIV-positive mothers
4. Anti-Retroviral Treatment (ART)
- Free ART is provided to all eligible PLHIV through a network of ART centres and Link ART Centres (LACs)
- 14.94 lakh PLHIV were receiving ART as of 2020-21 (including 1.06 lakh in the private sector)
- Viral load testing has expanded: 8.9 lakh tests in 2020-21 (up from 2.13 lakh in 2018-19)
5. Blood Safety
- Mandatory HIV testing of all donated blood
- Promotion of voluntary blood donation
- Regulation and quality assurance of blood banks under the National Blood Policy (2002)
6. HIV-TB Collaboration
NACO and NTEP (formerly RNTCP) jointly implement the "Three I's for HIV/TB":
- Intensified TB case finding among PLHIV
- Isoniazid Preventive Therapy (IPT) for PLHIV without active TB
- TB Infection Control in HIV care settings
Provider-initiated testing and counselling for TB patients has been scaled up, and 30 ART centres have capacity for CBNAAT-based TB detection.
7. STI/RTI Management
- Free diagnosis and treatment of sexually transmitted infections (STIs) and reproductive tract infections (RTIs) at STI clinics nationwide
- Syndromic case management approach
- Integration with TI projects for high-risk groups
HIV Surveillance System
NACO runs a comprehensive HIV Sentinel Surveillance (HSS) system that monitors HIV trends across populations:
| Surveillance Type | Target Group |
|---|
| HIV Sentinel Surveillance | HRGs, bridge populations, pregnant women at ANC |
| HIV Sero-Surveillance | General population samples |
| AIDS Case Surveillance | Reported AIDS cases |
| STD Surveillance | STI clinic attendees |
| Behavioural Surveillance | Risk behaviour trends |
| Integrated Surveillance | Overlap with TB and other diseases |
Districts are classified into 4 categories (A, B, C, D) based on ANC prevalence and HRG data, and programme resources are allocated accordingly:
- Category A: >1% ANC prevalence (high priority)
- Category B: <1% ANC but >5% HRG prevalence
- Category C & D: Lower prevalence states
Key Achievements
| Indicator | Achievement |
|---|
| New HIV infections reduction (2010-2021) | 46% decline |
| AIDS-related mortality reduction (2010-2020) | 82% reduction (vs. global average of 47%) |
| Adult HIV prevalence (2020) | 0.22% |
| Estimated PLHIV (2020) | ~23.18 lakh |
| PLHIV on ART (2020-21) | 14.94 lakh |
| States with high HIV burden | Andhra Pradesh, Telangana, Karnataka, Maharashtra, Tamil Nadu |
India's 82% reduction in AIDS-related deaths from 2010 to 2020 far surpasses the global average, making it one of the most remarkable achievements of the NACP.
Challenges
Despite major successes, NACO and NACP face ongoing challenges:
- First 95 gap: Only 78% of PLHIV know their status - a significant gap remains in HIV testing coverage
- Key population stigma: Stigma and discrimination continue to prevent HRGs from accessing services
- IDU/PWID interventions: Drug injection-driven HIV in the northeastern states remains difficult to address
- Private sector engagement: Many PLHIV seek care in the private sector and remain unnotified
- Paediatric HIV: Eliminating vertical transmission requires sustained ARV coverage, which remains below 75% in several northeastern states and UTs
- Funding dependency: A significant portion of the budget still relies on external donors (Global Fund, World Bank), raising sustainability concerns
- Viral suppression monitoring: Expanding viral load testing infrastructure beyond urban centres remains challenging
NACO and Global Alignment
NACO's strategy is aligned with:
- UNAIDS Global AIDS Strategy (2021-2026) - "End Inequalities, End AIDS"
- WHO Global Health Sector Strategies (2022-2030)
- Sustainable Development Goal 3.3 - End AIDS as a public health threat by 2030
- 95-95-95 UNAIDS targets by 2025
Sources: Park's Textbook of Preventive and Social Medicine (Ed. 26) |
IMPRI India - NACP Phase V Analysis |
PMC - India's HIV Programme |
NACO official website | Nature Scientific Reports (2025) - Vertical Transmission Progress